These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 18980829

  • 1. [Thyrotropin-secreting pituitary adenomas].
    Caron P.
    Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
    [Abstract] [Full Text] [Related]

  • 2. [Thyrotropin--TSH secreting pituitary tumor].
    Zieliński G, Podgórski JK, Warczyńska A, Koziarski A, Zgliczyński W.
    Przegl Lek; 2002 Jan; 59(12):1018-23. PubMed ID: 12731380
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis and treatment of pituitary adenomas.
    Chanson P, Salenave S.
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [Abstract] [Full Text] [Related]

  • 4. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P.
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [Abstract] [Full Text] [Related]

  • 5. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M, Fortunato M, Molteni L, Peretti E, Mortini P.
    Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
    [Abstract] [Full Text] [Related]

  • 8. Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience.
    Macchia E, Gasperi M, Lombardi M, Morselli L, Pinchera A, Acerbi G, Rossi G, Martino E.
    J Endocrinol Invest; 2009 Oct; 32(9):773-9. PubMed ID: 19636221
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

  • 10. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
    Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A.
    Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
    [Abstract] [Full Text] [Related]

  • 11. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P, Díez JJ.
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [Abstract] [Full Text] [Related]

  • 12. [Thyroid-stimulating hormone hypophyseal adenoma. A case report].
    Gannage MH, Maacaron C, Okais N, Halaby G.
    J Med Liban; 1997 Dec; 45(2):97-101. PubMed ID: 9289506
    [Abstract] [Full Text] [Related]

  • 13. [New elements in the diagnosis and treatment of thyrotropic pituitary adenomas with hyperthyroidism].
    Linquette M, Cappoen JP, Mazzuca M.
    Bull Acad Natl Med; 1989 Feb; 173(2):217-20; discussion 221-2. PubMed ID: 2765997
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center.
    Nazato DM, Abucham J.
    J Endocrinol Invest; 2018 Apr; 41(4):447-454. PubMed ID: 29022276
    [Abstract] [Full Text] [Related]

  • 15. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ, Erickson D, Castro MR, Atkinson JL.
    J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
    [Abstract] [Full Text] [Related]

  • 16. TSH-secreting pituitary adenomas: follow-up of 11 cases and review of the literature.
    Ness-Abramof R, Ishay A, Harel G, Sylvetzky N, Baron E, Greenman Y, Shimon I.
    Pituitary; 2007 Jul; 10(3):307-10. PubMed ID: 17347873
    [Abstract] [Full Text] [Related]

  • 17. Medical management of thyrotropin-secreting pituitary adenomas.
    Beck-Peccoz P, Persani L.
    Pituitary; 2002 Jul; 5(2):83-8. PubMed ID: 12675505
    [Abstract] [Full Text] [Related]

  • 18. [Thyrotropin-producing hypophyseal adenomas].
    Calvo Romero JM, Morales Pérez F, Alvarez Barreiro JA, Díaz Pérez de Madrid J.
    Rev Clin Esp; 1999 May; 199(5):285-7. PubMed ID: 10396149
    [Abstract] [Full Text] [Related]

  • 19. [Manifestations and prognosis of thyrotropin-secreting pituitary adenomas: a case series of three patients].
    Latrech H, Rousseau A, Le Marois E, Billaud L, Bertagna X, Azzoug S, Raffin-Sanson ML.
    Rev Med Interne; 2010 Dec; 31(12):858-62. PubMed ID: 21074296
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
    Wu YY, Chang HY, Lin JD, Chen KW, Huang YY, Jung SM.
    J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.